Zoetis and Holstein Association USA release a new list identifying top-ranking bulls for wellness traits available through CLARIFIDE® Plus from Zoetis.

CLARIFIDE Plus is the first commercially available, U.S.-based genomic test that offers dairy producers the ability to directly predict disease risks in Holstein cattle. The bull lists will include official industry rankings for the Dairy Wellness Profit Index™ (DWP$™) and Wellness Trait Index™ (WT$™). The two economic selection indexes provide a path for dairy producers to rank and select for comprehensive genetic improvements. With advanced genomic predictions for wellness traits, CLARIFIDE Plus provides direct indication of the genetic risk for six of the most common and costly animal health diseases: mastitis, lameness, metritis, retained placenta, displaced abomasum and ketosis.

“We felt it was important to develop these top-ranking bull lists as another tool to help producers use the technology more effectively, and we have received consistent feedback from Zoetis and Holstein Association USA customers asking for this resource,” said Cheryl Marti, associate director, U.S. Marketing, Dairy Genetics and Reproduction, Zoetis. “We’ve been very pleased to see such enthusiasm and recognition for the benefits of CLARIFIDE Plus to help progress the dairy industry and overall herd health and profitability.”